Cite
MLA Citation
Shasha Lu et al.. “The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.” Leukemia & lymphoma, vol. 56, no. 4, n.d., pp. 1027–1032. http://access.bl.uk/ark:/81055/vdc_100025193227.0x00003c